Cargando…
Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment
Background: Ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) are used to treat patients with asymptomatic or mildly symptomatic gallstone disease. This study was conducted to evaluate the efficacy of gallbladder (GB) stone dissolution by UDCA/CDCA and the impact of treatment on gut micro...
Autores principales: | Lee, Jungnam, Lee, Sohee, Kim, Hanul, Bae, Jaewoong, Park, Jin-Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045859/ https://www.ncbi.nlm.nih.gov/pubmed/36979756 http://dx.doi.org/10.3390/biomedicines11030777 |
Ejemplares similares
-
Bile Microbiome in Patients with Recurrent Common Bile Duct Stones and Correlation with the Duodenal Microbiome
por: Lee, Jungnam, et al.
Publicado: (2022) -
The Role of the Bile Microbiome in Common Bile Duct Stone Development
por: Lee, Jungnam, et al.
Publicado: (2023) -
Differential effects of norUDCA and UDCA in obstructive cholestasis in mice
por: Fickert, Peter, et al.
Publicado: (2013) -
Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride
por: Zappaterra, Federico, et al.
Publicado: (2021) -
Gallbladder Pseudodiverticulosis Mimicking a Multiseptate Gallbladder with Stones
por: Lee, Tae Hoon, et al.
Publicado: (2009)